25 percent of COVID patients have post-acute symptoms; Report highlights emerging care needs
By
Alicia Lasek
Jun 18, 2021
A analysis based on nearly two million private U.S. healthcare claims has identified the most common post-COVID conditions with a focus on age, gender, mental health conditions and mortality. Even 19%...
Most senior living facilities short on coronavirus-fighting supplies, survey finds
By
Alicia Lasek
Mar 17, 2020
More than two-thirds of the nation’s senior living facilities report trouble sourcing equipment, particularly N95 respirators.
Ambien alternative? FDA approves insomnia drug that improves sleep in seniors
By
Alicia Lasek
Jan 01, 2020
New insomnia medication lemborexant compared favorably to an extended release form of Ambien in a late-stage clinical trial.
HHS sets national plan to ‘end cancer as we know it’
By
Alicia Lasek
Apr 04, 2023
A new framework sets goals for early detection and prevention; development of effective treatments; eliminating cancer-care related inequalities; and supporting optimal care delivery.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Unforeseen consequences pile up in race to find COVID-19 treatments
By
Alicia Lasek
Mar 25, 2020
The national attention gained by an experimental drug and two existing medications has led to unintended trouble for patients.
‘No reliable evidence’ for most antidepressants in relief of long-term pain, review finds
By
Alicia Lasek
May 18, 2023
With the exception of duloxetine, there is not enough reliable evidence to support the use of most antidepressant medications in the relief of chronic pain, a new review and meta-analysis has shown.